CBI’s Targeted Cancer Therapy Summit

Venue: Washington, DC

Location: Washington, DC, United States

Event Date/Time: Jun 26, 2008
Report as Spam


Targeted cancer therapies use drugs that block the growth and spread of cancer by interfering with specific molecules that contribute to tumor growth. CBI’s first ever Targeted Cancer Therapy Summit provides unique networking opportunities for R&D executives who can identify and evaluate molecular targets that may be candidates for new oncology treatments. Clinical data for novel molecular targeted cancer therapies are also presented.
Must attend information includes:
• Updates on the cellular components of tumor biology
• Hear positive trial data that led to the approval of Nexavar in renal cell and hepatocellular carcinoma
• Examine predictive biomarkers that can be deployed in early clinical studies
• Explore targeting the urokinase plasminogen activator receptor (uPAR) as a therapeutic strategy for the inhibition of tumor progression
• Learn about the selective inhibition of tumor VEGF production – benefits and possible mechanisms